Oral Dosage Form New Animal Drugs; Oxfendazole Suspension
other · Food and Drug Administration · Rule · Published 2007-03-09 · Effective 2007-03-09 · 72 FR 10595
Document
Document number
E7-4205
Federal Register citation
72 FR 10595
CFR reference
21 CFR 520
Type
Rule
Action
Final rule.
Category
other
Sub-agency
Food and Drug Administration
Publication date
2007-03-09
Effective date
2007-03-09
Abstract
The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of a supplemental new animal drug application (NADA) filed by Fort Dodge Animal Health, Division of Wyeth. The supplemental NADA provides for over-the-counter (OTC) marketing status for oral use of oxfendazole suspension in cattle.